Dr. Roland B. Scott, a pediatrician and allergy expert, gained international prominence as an authority on sickle cell disease and a champion in the fight against it. Dr. Scott was a driving force behind the Sickle Cell Anemia Control Act of 1971, which established comprehensive research and treatment centers around the country for the disease.Dr. Scott, who was Chairman of Pediatrics at Howard University in Washington from 1949 to 1973, was trained as an allergist but turned his attention to sickle cell anemia in the 1950's after he noticed a high number of African-American children appearing in the Howard Hospital emergency room with complications of the disease. Through his research, Dr. Scott became a pre-eminent authority on sickle cell disease, a hereditary blood disorder, and lobbied for a national research and treatment effort.In 1972, with a grant from the National Institutes of Health, Dr. Scott founded the Howard University Center for Sickle Cell Disease. He was the director of the Center until 1990, when he retired. Because of the efforts of Dr. Scott and others, the federal government now spends about $45 million a year on sickle cell disease and sponsors the operation of 10 comprehensive treatment and research centers.
Howard University Center for Sickle Cell Disease, (HUCSCD) has initiated a transition program for sickle cell disease patients, ages 13-21 years. This is based on the need for adequate transition of sickle cell disease patients to adult care. The Adult Transition Program (ATP) was designed to ensure a comprehensive and successful transition of pediatric age patients to adult care. The program is comprised of educational workshops, survey assessments on knowledge, attitude, and psychosocial issues of SCD patients.
The program is highly informative and beneficial for the young adults as well as their caregivers.
ATP is not designed to take over medical care but rather to empower participants for future healthcare challenges. It is therefore requested that patients with sickle cell disease in the above age group be referred to the program. Pediatricians may contact potential participants and invite them to complete a referral form, and fax to 202-232-6719. Interested participants will be contacted for an interview and meet with the transition team.
The program was previously funded by the Government of the District of Columbia, Department of Health, and Community Health Administration. Call 202-865-8292 for more information.
We love our customers and community partners, so feel free to call or visit during normal business hours.
For information about the Center for Sickle Cell Disease and it's Adult Transition Program, please call our main line at (202) 865-8284 or send your questions or comments to: email@example.com. Normal office hours are 8:30AM to 5:00PM.
1840 7th Street NW Washington DC 20001